Between 1993 and 2002, 58 GSB III total elbow replacements were implanted in 45 patients with rheumatoid arthritis by the same surgeon. At the most recent follow-up, five patients had died (five elbows) and six (nine elbows) had been lost to follow-up, leaving 44 total elbow replacements in 34 patients available for clinical and radiological review at a mean follow-up of 74 months (25 to 143). There were 26 women and eight men with a mean age at operation of 55.7 years (24 to 77).
Between 1993 and 2002, 58 GSB III total elbow replacements were implanted in 45 patients with rheumatoid arthritis by the same surgeon. At the most recent follow-up, five patients had died (five elbows) and six (nine elbows) had been lost to follow-up, leaving 44 total elbow replacements in 34 patients available for clinical and radiological review at a mean follow-up of 74 months (25 to 143). There were 26 women and eight men with a mean age at operation of 55.7 years (24 to 77).
At the latest follow-up, 31 excellent (70%), six good (14%), three fair (7%) and four poor (9%) results were noted according to the Mayo elbow performance score. Five humeral (11%) and one ulnar (2%) component were loose according to radiological criteria (type III or type IV). Of the 44 prostheses, two (5%) had been revised, one for type-IV humeral loosening after follow-up for ten years and one for fracture of the ulnar component. Seven elbows had post-operative dysfunction of the ulnar nerve, which was transient in five and permanent in two.
Despite an increased incidence of loosening with time, the GSB III prosthesis has given favourable mid-term results in patients with rheumatoid arthritis.
Early designs of implant for total elbow replacement had rigid hinges and their results were disappointing because of a high rate of loosening. 1 Non-constrained and semiconstrained implants were developed in the mid 1970s. The Gschwend/Scheier/Bähler (GSB) III implant (Zimmer, Warsaw, Indiana) ( Fig. 1) is a semiconstrained total elbow replacement hinged prosthesis. Its hinge allows a clearance of 4˚ in either direction between the metal ulnar stud, and the high-density polyethylene cover of the humeral component. 2 The long-term results of its originators are excellent. 3 However, recent reports with a shorter follow-up have shown contradictory outcomes. [4] [5] [6] Our early results using the GSB III prosthesis were excellent at a mean follow-up of three years. 7 In this retrospective study, we report our mid-term results and give additional information on this prosthesis.
Patients and Methods
Between January 1993 and December 2002, 58 primary total elbow replacements in 45 patients were performed by the same surgeon (FC) using the GSB III prosthesis. The indication in all cases was a painful rheumatoid elbow with severe disability and/or instability. Five patients (five elbows) died before followup, four (five elbows) were unwilling to return for review and two (four elbows) were lost to follow-up. We therefore reviewed 44 elbows in 34 patients (26 women, 8 men) with a mean age of 55.7 years (24 to 77). Of the 17 patients (20 elbows) from the previous study, 7 11 (12 elbows) had further follow-up and six (8 elbows) were not available: three of whom (3 elbows) had died and three (5 elbows) had no further follow-up. A comparative study of the patients reviewed and lost to follow-up in the present series found a significant difference in terms of age (Students t-test, p < 0.001) and pre-operative radiological staging (Fisher's exact test, p = 0.04). This difference was especially important for those who had died. Of the 11 patients (14 elbows) not available for this study, complete revision of the prosthesis had been necessary for humeral aseptic loosening in one. In all the others, at the last follow-up available, no clinical or radiological signs of loosening had been noted.
The mean follow-up was 74 months (25 to 143). The mean duration between the onset of arthritis and total elbow replacement was 17.4 years (3 to 30). At operation, four patients were not taking any medication, 20 were receiving steroids, 19 methotrexate, one antitissue necrosing factor alpha and one immuno-therapy (interleukin 10). A total of 13 patients received a combination of these medications.
A total of 20 elbows had previously been treated by injections of steroid and 21 by isotopic synoviorthesis. Four elbows had undergone previous surgery. In 20 elbows total elbow replacement had been the first operation in the upper limb and in 24, one or more procedures had been undertaken.
The elbow replacements were performed under general anaesthesia using a standard technique. 3 The clinical and radiological reviews were undertaken by an independent surgeon (MC), who was not involved in the operation.
Clinical evaluation was carried out using the Mayo Elbow performance score. 8 This is based on pain (45 points), movement of the joint (20), stability (10) and daily activity (25). A result is considered to be excellent when the score is between 90 and 100 points, good at between 75 and 89, fair at between 60 and 74, and poor when it is below 60 points. Ulnar neuropathy was classified according to McGowan, 9 as stage 1 (isolated paraesthesiae), stage 2 (minor weakness) and stage 3 (weakness with muscular atrophy). The condition of the skin was also taken into account, as were complications before and after the sixth week.
The pre-operative radiographs were graded according to the classifications of Larsen, Dale and Eek 10 and Morrey and Adams. 8 We found one elbow in stage II, 19 in stage III, 22 in stage IV and two in stage V according to Larsen et al 10 and one in grade II, 41 in grade III and two in grade IV according to Morrey and Adams. 8 Radiological evaluation at follow-up was based on two standard views. Radiolucent lines were analysed according to the classification of Morrey, Adams and Bryan 11 as type 0, with no radiolucency or a line < 1 mm thick involving less than 50% of the cement-bone interface, type I with a line ≥ 1 mm thick involving less than 50% of the interface, type II with a line > 1 mm thick involving more than 50% of the interface, type III with a line > 2 mm thick involving the whole of the interface and type IV with gross loosening. Statistical analysis. This was carried out using SAS software (version 8.2; SAS institute, Cary, North Carolina). All continuous measures were given as the mean and SD. For comparative analysis, the level of significance was set at p < 0.05. To compare paired samples, Student's t-test was (15) 2 (5) 3 (7) Severe (0) 41 (93) 3 (7) Arc of movement (˚; 20 points) > 100 (20) 6 (14) 32 (72) 50 to 99 (10) 21 (48) 12 (28) < 49 (5) 17 (38) used when the distribution was normal and the Wilcoxon signed-rank test in other cases. The chi-squared test was used to assess the relationship between two sets of qualitative data when required conditions were satisfied. Otherwise, Fisher's exact test was used.
Results
Clinical findings (Table I ). The Mayo elbow performance score in all the elbows significantly improved after the operation (p < 0.001). The mean score increased from 27 (5 to 50) pre-operatively to 87.5 (30 to 100) at review (p < 0.001). At the latest follow-up, 31 elbows (70%) had an excellent result (Fig. 2) , six (14%) were good, three (7%) fair and four (9%) poor. Of the 12 elbows from our previous study 7 with a longer follow-up, five had an excellent result, three good, one fair and three poor.
The mean increase in the range of flexion and extension was 34˚ ± 32˚. The mean fixed flexion decreased from 41.5±
28.5˚ to 29˚ ± 14.3˚ which was not significant, whereas the mean flexion increased significantly from 112˚ ± 15.3t o 133.7˚ ± 7.3˚ (p < 0.001). At follow-up the mean pronation was 65˚ ± 13.8˚ (25˚ to 90˚) and the mean supination was 73˚ ± 17.4˚ (10˚ to 95˚). (Table II) . On the humeral side six radiolucent lines according to Morrey et al 11 were seen. Of these, four (three type IV and one type III) occurred in the 12 humeral components with a longer follow-up. On the ulnar side two radiolucent lines were seen, of which one (type IV) occurred in the 12 with a longer follow-up.
Radiological findings
Two failures were noted, a disassembly after type-IV loosening, and a fracture of the ulnar component 97 months after operation.
Complications. There were three intra-operative complications, two of which were inconsequential perforations of the ulnar shaft, and the other a fracture of the lateral humeral condyle, which was fixed by a screw. These complications did not influence the final result.
Seven cases of delayed wound healing and one haematoma were noted in the immediate post-operative period. At two months a 54-year-old woman sustained an undisplaced fracture of the olecranon as a result of lifting a heavy weight. Immobilisation for one month gave healing without affecting the final result.
At the latest follow-up, no evidence of insufficiency of the triceps was found, and all patients could extend their elbows against gravity.
Before operation, an ulnar-nerve deficit according to the system of MacGowan 9 was present in eight patients (six stage 1 and two stage 2). Post-operatively, one patient had persistent paraesthesiae and there were six further nerve deficits (five stage 1 and one stage 2). Of these, two remained at the latest follow-up and the others resolved spontaneously during the first post-operative months. In addition to the two unresolved cases, four elbows had developed a deficit of the ulnar nerve (three stage 1 and one stage 2) at the latest follow-up, thus giving six late ulnar neuropathies. No further operations were performed for these lesions.
Discussion
In late-stage rheumatoid disease of the elbow, with loss of bone stock and ligamentous weakness, unconstrained arthroplasty is contraindicated. 12 A semiconstrained prosthesis such as the GSB III allows intrinsic stability which compensates partially for soft-tissue insufficiency. Good long-term survivorship has been demonstrated.
Our rate of good and excellent results (84%) is satisfactory but there were seven (16%) fair or poor results. Of these, four were in the group of 12 elbows with further follow-up from our previous study, 7 suggesting that the outcome tends to deteriorate with time.
Radiological loosening is defined by most authors as a complete and progressive radiolucent line around the prosthesis and/or a change in the orientation of the implant. 3, 8 The reported rate of loosening for the GSB III implant varies from 9.1% to 25% at a mean follow-up of 5 to 7.5 years, [4] [5] [6] with the humeral component three times more likely to loosen than the ulnar. Our results agree with those of previous studies. We had six cases of loosening (five humeral and one ulnar) among the 88 components (6.8%). The higher rate of loosening on the humeral side can be explained by increased forces at the posterior interface due to posterior translation of the distal part of the stem and the humeral hinge mechanism during lifting. This was confirmed by a finite-element model simulation of the GSB III prosthesis, 13 in which the maximum Von Mises stress 13 was located at the posterior side of the humeral implant between the hinge and proximal stem at 120˚ of flexion. Any reduction of force at the bone-cement interface should reduce loosening. Release of the collateral ligaments during implantation, increases varus-valgus laxity and thus the peak force at the interfaces. 14 We have always used a transtricipital approach which preserves the collateral ligaments and we believe that this contributes to a higher intrinsic stability of the elbow and a lower rate of loosening.
Four elbows had a poor result. One patient was an active 63-year-old man who fractured the ulnar component eight years after operation. This mechanical failure could be explained by his continuation of activities such as tennis, which are not recommended after total elbow replacement. The GSB III was exchanged for another semiconstrained implant (Coonrad-Morrey; Zimmer, Warsaw, Indiana). In the second patient, a 53-year-old woman who had bilateral arthroplasties, on the dominant side the humeral component which had been implanted ten years earlier developed type IV loosening according to Morrey and Adams, 8 and was revised to a Coonrad-Morrey prosthesis. The third patient was a 52-year-old woman. During implantation, perforation of the shaft of the ulna occurred without consequence. At 65 months post-operatively, she had severe pain, gross instability and type II loosening of both components. The fourth poor result occurred in a 53-yearold woman with bilateral total elbow replacement. On the dominant side, the collateral ligaments were released because of stiffness. She developed type IV loosening of both components at 97 months post-operatively, with migration and disassembly (Fig. 3) .
The main complications of total elbow replacement are deep infection, ulnar neuropathy and disassembly of the components. In their meta-analysis, Gschwend, Simmen and Matejovsky 15 found a rate of infection of 8.1%. In our study, we had no cases of deep infection but seven arthroplasties had delayed healing. This was explained by premature rehabilitation. 5 Therefore, we believe that during the first three weeks after operation a splint at 90˚ should be used, and removed only for gentle physiotherapy.
Ulnar neuropathy in rheumatoid arthritis is a consequence of compression by aggressive synovitis and valgus instability. 12 Although eight elbows had pre-operative dysfunction of the ulnar nerve only one had persistent paraesthesiae. This supports the hypothesis that pre-operative dysfunction of the ulnar nerve does not predispose to postoperative neuropathy. 16 The incidence of early postoperative lesions in the ulnar nerve was reported as 10.5% in a meta-analysis, 15 and in the studies concerning only semiconstrained prosthesis, ranged between 3% and 20%. [3] [4] [5] [6] [7] [8] 17, 18 Although we had the same policy for management of the ulnar nerve as that of Gschwend et al, 15 i.e. neurolysis without anterior transposition, we noted early post-operative injuries to the ulnar nerve in 14% of patients. Of these, only two had persistent paraesthesiae at the latest follow-up. Usually, this is attributed to the use of a tourniquet and thus the incidence of injuries to the ulnar nerve within the early post-operative days is underestimated. 19 Intra-operative monitoring of the function of the ulnar nerve has shown constant electrophysiological abnormalities during dislocation of the elbow required for bone preparation. 19 The unlocked design of the GSB III prosthesis can lead to disassembly and dislocation of the elbow. In their early experience, Gschwend et al 3 noted nine such cases in 65 prostheses within the immediate post-operative period and Schneeberger et al 6 reported a similar rate of disassembly (14.2%). Several causative factors were suggested such as excessive soft-tissue release, malposition of the components and ligamentous imbalance. 4, 6, 15 We had only one late disassembly after complete aseptic loosening and migration of both components.
In summary, total elbow replacement with the GSB III prosthesis gave satisfactory mid-term results with a good or excellent result in more than 80% of elbows. However, the outcome tended to deteriorate with time because of loosening. Further follow-up is required to analyse rates of loosening in the long term. 
